Skip to content

News and stories

Follow the latest releases and stories from Orion and find links to media contacts, image bank and more.

Stock exchange releases

All releases 

Press releases

10/14/2026 Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026
10/6/2026 Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
10/5/2026 Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026

All releases 

Subscribe to releases

Subscribe Orion Corporation's stock exchange and press releases to your e-mail.

Subscribe

Orion Pharma content bank

You can find and download Orion Pharma brand images and assets such as logos in the public content bank.

Visit content bank

Content themes

Corporate Communications contacts

Media

Please note that we only respond to media inquiries.

media@orionpharma.com

+358509662244
Christina Weber-Villumsen

Vice President, Corporate Communications, Brand and Public Affairs

christina.weber-villumsen@orionpharma.com

+358504635247
Mari Lautsuo

Communications Manager

mari.lautsuo@orionpharma.com

+358104262156
Valtteri Manninen

Communications Business Partner, Global Operations

valtteri.manninen@orionpharma.com

+358509662303
Verna Vuorinen

Communications & Brand Manager

verna.vuorinen@orionpharma.com

+358104262211
Samuli Koski

Communications Coordinator

samuli.koski@orionpharma.com

+358401650356

Disclosure policy

In its communications, Orion Corporation complies with valid legislation, the rules and insider guidelines of Nasdaq Helsinki Ltd, the regulations and guidelines of the Financial Supervisory Authority and the instructions and principles defined internally in the company.